Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
Novo Nordisk has announced a sweeping reduction in the cost of its blockbuster diabetes drug Ozempic, cutting the monthly price for cash-paying U.S. patients with type 2 diabetes from its previous list price of nearly $1,000 to just $499. The news follows mounting calls for greater drug affordability and may signal a pivotal shift in … Read more